2025-09-04 - Analysis Report
Okay, here's an analysis of TG Therapeutics Inc. (TGTX) based on the information provided, focusing on key metrics and recent developments.

**Report on TG Therapeutics Inc. (TGTX)**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** TGTX
*   **Company Overview:** TG Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
*   **TGTX Cumulative Return:** 62.67%
*   **VOO Cumulative Return:** 99.17%
*   **Absolute Divergence:** -52.0
*   **Relative Divergence:** 11.4

**Analysis:** TGTX has significantly underperformed the S&P 500 (VOO) over the analyzed period.  The negative divergence indicates TGTX's returns lag behind the market benchmark. A relative divergence of 11.4 means the current divergence is relatively low compared to historical divergences.

**Alpha, Beta Analysis**

| Year       | CAGR   | MDD   | Alpha   | Beta   | Cap(B) |
|------------|--------|-------|---------|--------|--------|
| 2015-2017  | -6.0%  | 56.5% | -35.0%  | -0.1   | 1.3    |
| 2016-2018  | -8.0%  | 58.6% | -26.0%  | 0.0    | 0.7    |
| 2017-2019  | 74.0%  | 58.6% | 44.0%   | 0.0    | 1.8    |
| 2018-2020  | 402.0% | 58.6% | 382.0%  | -0.4   | 8.2    |
| 2019-2021  | 125.0% | 63.5% | 76.0%   | -0.5   | 3.0    |
| 2020-2022  | -76.0% | 70.4% | -78.0%  | -0.6   | 1.9    |
| 2021-2023  | -350.0%| 70.4% | -368.0% | -0.8   | 2.7    |
| 2022-2024  | 71.0%  | 73.1% | 45.0%   | -0.9   | 4.8    |
| 2023-2025  | 70.0%  | 73.1% | 19.0%   | 0.4    | 5.0    |

**Analysis:**

*   **CAGR:** Wide range of performance, with significant positive returns in some periods and large losses in others, indicating high volatility.
*   **MDD:**  Maximum Drawdown is consistently high, showing significant potential for loss.
*   **Alpha:** Alpha values fluctuate significantly, demonstrating the stock's performance relative to the market benchmark.
*   **Beta:** Beta values are generally low, indicating the stock's sensitivity to market movements.

**2. Recent Price Action**

*   **Current Price:** 31.385
*   **Last Market Data:** price: 31.38, previousClose: 29.73, change: 5.55
*   **5-Day Moving Average:** 29.305
*   **20-Day Moving Average:** 28.258
*   **60-Day Moving Average:** 33.9655

**Analysis:** The price is currently above both the 5-day and 20-day moving averages, suggesting a short-term upward trend. However, it is below the 60-day moving average, which might indicate a longer-term resistance level.  The significant positive change (5.55) in the last market indicates a strong upward price movement.

**3. Technical Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.3403 (Low Risk)
*   **RSI:** 78.45 (Overbought)
*   **PPO:** 1.8529
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (25 shares - Caution - MRI:0.34) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-09-02)
*   **Recent Relative Divergence Change (20-day):** -0.2 (Short-term decrease)
*   **Expected Return:** -366.8% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** The low MRI suggests a relatively low level of market risk for this investment, but this is contradicted by other factors.
*   **RSI:** The high RSI indicates the stock is overbought and may be due for a correction.
*   **PPO:** Positive PPO suggests bullish momentum, but needs to be considered alongside the overbought RSI.
*   **Hybrid Signal:** Indicates caution, with a recommendation to buy a portion of available cash.
*   **Relative Divergence Change:**  A decrease in relative divergence indicates a short-term underperformance compared to the S&P 500.
*   **Expected Return:** A very negative expected return suggests significant underperformance relative to the S&P 500 over the long term, potentially indicating high risk or overvaluation.

**4. Recent News & Events**

*   **[2025-09-01]:** Major business developments, regulatory changes, or market events.
*   **[2025-08-31]:** Analyst discussions regarding performance, industry trends, and economic factors.
*   **[2025-09-02]:** Notable stock volatility influenced by news, earnings, or executive actions.
*   **[2025-09-03]:** Market experts highlighting both risks and opportunities.

**Analysis:** The news snippets suggest potential catalysts (positive or negative) influencing the stock.  Volatility is mentioned, requiring careful monitoring of company announcements.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출    |
|------------|-------|---------|
| 2025-08-08 | 0.19  | 0.14 B$ |
| 2025-05-09 | 0.03  | 0.12 B$ |
| 2024-11-07 | 0.03  | 0.08 B$ |
| 2024-08-09 | 0.05  | 0.07 B$ |
| 2025-08-08 | 0.05  | 0.07 B$ |

**Analysis:**

*   The most recent EPS (0.19) is significantly higher than previous quarters.
*   Revenue has shown an increasing trend.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $0.14B   | 86.58%        |
| 2025-03-31 | $0.12B   | 87.14%        |
| 2024-12-31 | $0.11B   | 85.77%        |
| 2024-09-30 | $0.08B   | 88.86%        |
| 2024-06-30 | $0.07B   | 88.70%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE      |
|------------|----------|----------|
| 2025-06-30 | $0.28B   | 10.20%   |
| 2025-03-31 | $0.24B   | 2.13%    |
| 2024-12-31 | $0.22B   | 10.49%   |
| 2024-09-30 | $0.19B   | 2.02%    |
| 2024-06-30 | $0.18B   | 3.87%    |

**Analysis:**

*   **Revenue:** Steadily increasing revenue indicates positive growth.
*   **Profit Margin:** Consistently high profit margins suggest efficient cost management.
*   **Equity:** Increasing equity indicates financial strength.
*   **ROE:** Fluctuations in ROE suggest varying levels of profitability over time.

**7. Overall Analysis**

*   **Underperformance:** TGTX has significantly underperformed the S&P 500. The long-term expected return is extremely negative, suggesting the company is riskier than the benchmark.
*   **Volatility:** The stock exhibits high volatility, as evidenced by the wide range of historical returns and recent news events.
*   **Financial Improvement:** Recent earnings and financial data show positive trends in revenue, profitability, and equity.
*   **Technical Signals:** The overbought RSI suggests caution in the short term, while the PPO indicates bullish momentum.
*   **News & Events:** Recent news suggests important events are affecting the stock, warranting close monitoring.

**Conclusion:**

TGTX is a high-risk, high-reward investment. While recent financial performance shows promise, the stock has historically underperformed the market and exhibits high volatility. The negative expected return suggests caution and careful consideration of risk tolerance. Investors should closely monitor company news and financial results to make informed decisions. The recent positive price action could be a short-term rally or the start of a sustained uptrend, but the overbought RSI indicates potential for a pullback.
